Compare Cytokinetics Inc (CYTK) vs YieldMax TSLA Option Income Strategy ETF (TSLY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cytokinetics Inc vs YieldMax TSLA Option Income Strategy ETF — how do they compare? Cytokinetics Inc trades at $76.62 (market cap $10.63B), while YieldMax TSLA Option Income Strategy ETF trades at $21.91. The key difference: Cytokinetics Inc is trading nearer its 52-week high, YieldMax TSLA Option Income Strategy ETF nearer its low. Which is the better fit depends on your goals.
| CYTK | TSLY | |
|---|---|---|
Market Cap | $10.63B | — |
Sector | Technology | Income / Options Overlay |
52-Week High | $87.26 | $48.25 |
52-Week Low | $34.31 | $20.49 |
Enterprise Value | $10.74B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cytokinetics Inc
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →About YieldMax TSLA Option Income Strategy ETF
TSLY is an actively managed ETF that seeks to provide high monthly income by employing a synthetic covered call strategy on Tesla, Inc. (TSLA). It does not own Tesla stock directly; instead, it uses a combination of call and put options to simulate long exposure while simultaneously selling call options to collect premiums. It is designed for income-focused investors who are willing to trade TSLA's potential upside for immediate, aggressive yield.
Read more on TSLY →
